$GBLX
GB SCIENCES INC

2023 Q4 Form 10-Q Financial Statement

#000143774923032645 Filed on November 20, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue $0.00 $0.00
YoY Change
Gross Profit $0.00 $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $234.0K $551.5K
YoY Change -42.55% 99.93%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $620.00
YoY Change -100.0% -96.96%
% of Gross Profit
Operating Expenses $234.0K $551.5K
YoY Change -42.55% 99.93%
Operating Profit -$234.0K -$551.5K
YoY Change -42.55% 99.93%
Interest Expense $38.27K $42.74K
YoY Change -7.72% 14.84%
% of Operating Profit
Other Income/Expense, Net $46.73K $117.3K
YoY Change -212.69% -415.06%
Pretax Income -$187.3K -$434.2K
YoY Change -58.27% 38.71%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$187.3K -$434.2K
YoY Change -58.27% 38.71%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 402.7M 381.9M
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $17.46K $104.5K
YoY Change -93.63% -84.11%
Cash & Equivalents $17.46K $104.5K
Short-Term Investments
Other Short-Term Assets $129.7K $129.7K
YoY Change -18.55% -41.26%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $147.1K $234.2K
YoY Change -66.04% -73.34%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change -100.0% -100.0%
TOTAL ASSETS
Total Short-Term Assets $147.1K $234.2K
Total Long-Term Assets $0.00 $0.00
Total Assets $147.1K $234.2K
YoY Change -94.73% -92.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.020M $1.992M
YoY Change 15.33% 25.92%
Accrued Expenses $75.63K $75.63K
YoY Change 99.28% 343.02%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.437M $1.427M
YoY Change 3.58% 21.94%
Total Short-Term Liabilities $4.919M $4.852M
YoY Change 11.9% 18.6%
LONG-TERM LIABILITIES
Long-Term Debt $75.00K $75.00K
YoY Change 893.38% -65.85%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $75.00K $75.00K
YoY Change 893.38% -65.85%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.919M $4.852M
Total Long-Term Liabilities $75.00K $75.00K
Total Liabilities $4.994M $4.927M
YoY Change 13.41% 14.3%
SHAREHOLDERS EQUITY
Retained Earnings -$109.6M -$109.4M
YoY Change 3.55% 3.82%
Common Stock $40.72K $40.39K
YoY Change 7.38% 6.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$4.847M -$4.693M
YoY Change
Total Liabilities & Shareholders Equity $147.1K $234.2K
YoY Change -94.73% -92.49%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$187.3K -$434.2K
YoY Change -58.27% 38.71%
Depreciation, Depletion And Amortization $0.00 $620.00
YoY Change -100.0% -96.96%
Cash From Operating Activities -$205.4K -$407.8K
YoY Change -48.57% -33.74%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities $85.00K $235.0K
YoY Change
Cash From Investing Activities $85.00K $235.0K
YoY Change -6490.98% -875.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 33.34K 247.4K
YoY Change 95.89% -80.2%
NET CHANGE
Cash From Operating Activities -205.4K -407.8K
Cash From Investing Activities 85.00K 235.0K
Cash From Financing Activities 33.34K 247.4K
Net Change In Cash -87.06K 74.61K
YoY Change -77.31% -87.64%
FREE CASH FLOW
Cash From Operating Activities -$205.4K -$407.8K
Capital Expenditures $0.00 $0.00
Free Cash Flow -$205.4K -$407.8K
YoY Change -48.74% -30.31%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2432492 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2390297 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
402737695
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
402737695
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
381872561
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
381872561
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55462
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
59-3733133
dei Entity Address Address Line1
EntityAddressAddressLine1
9205 W. Russell Road, Suite 240
dei Entity Address City Or Town
EntityAddressCityOrTown
Las Vegas
dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89148
dei City Area Code
CityAreaCode
866
dei Local Phone Number
LocalPhoneNumber
721-0297
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
402737695
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
104530 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
109912 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
129655 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
199592 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
234185 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
309504 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
0 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
42819 usd
CY2023Q3 us-gaap Assets
Assets
234185 usd
CY2022Q4 us-gaap Assets
Assets
352323 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
399796 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
346806 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
75628 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
75628 usd
CY2023Q3 gblx Notes Convertible Notes Payable And Line Of Credit Current
NotesConvertibleNotesPayableAndLineOfCreditCurrent
1426633 usd
CY2022Q4 gblx Notes Convertible Notes Payable And Line Of Credit Current
NotesConvertibleNotesPayableAndLineOfCreditCurrent
935000 usd
CY2023Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
461077 usd
CY2023Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
958455 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
958455 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4852311 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4759706 usd
CY2023Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
75000 usd
CY2022Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
CY2023Q3 us-gaap Liabilities
Liabilities
4927311 usd
CY2022Q4 us-gaap Liabilities
Liabilities
4759706 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
40388 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
38187 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
104679155 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
104259745 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-109412669 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-108705315 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-4693126 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-4407383 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
234185 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
352323 usd
CY2023Q3 us-gaap Revenues
Revenues
0 usd
CY2022Q3 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
us-gaap Cost Of Revenue
CostOfRevenue
0 usd
us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
0 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
0 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
551491 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
275839 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
816614 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
735357 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-551491 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-275839 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-816614 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-735357 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
42742 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
37218 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-69937 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
126794 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
9060 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-102254 usd
gblx Increase Decrease In Accrued Liabilities Excluding Interest Payable
IncreaseDecreaseInAccruedLiabilitiesExcludingInterestPayable
0 usd
us-gaap Interest Expense
InterestExpense
83546 usd
us-gaap Interest Expense
InterestExpense
75789 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
160000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
235000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2023Q3 gblx Gain Loss On Impairment Of Capitalized Patent Costs
GainLossOnImpairmentOfCapitalizedPatentCosts
0 usd
CY2022Q3 gblx Gain Loss On Impairment Of Capitalized Patent Costs
GainLossOnImpairmentOfCapitalizedPatentCosts
0 usd
gblx Gain Loss On Impairment Of Capitalized Patent Costs
GainLossOnImpairmentOfCapitalizedPatentCosts
-42194 usd
gblx Gain Loss On Impairment Of Capitalized Patent Costs
GainLossOnImpairmentOfCapitalizedPatentCosts
0 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
117258 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-37218 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
109260 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-75789 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-434233 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-313057 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-707354 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-811146 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-434233 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-313057 usd
us-gaap Net Income Loss
NetIncomeLoss
-707354 usd
us-gaap Net Income Loss
NetIncomeLoss
-811146 usd
CY2023Q3 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
269218 usd
CY2022Q3 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
-0 usd
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
269218 usd
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
-0 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-703451 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-313057 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-976572 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-811146 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
395738723
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
346269298
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
388843528
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
336062449
us-gaap Profit Loss
ProfitLoss
-707354 usd
us-gaap Profit Loss
ProfitLoss
-811146 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
624 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
40492 usd
us-gaap Share Based Compensation
ShareBasedCompensation
219168 usd
us-gaap Share Based Compensation
ShareBasedCompensation
13000 usd
gblx Gain Loss On Collection Of Notes Receivable
GainLossOnCollectionOfNotesReceivable
235000 usd
gblx Gain Loss On Collection Of Notes Receivable
GainLossOnCollectionOfNotesReceivable
-0 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
30556 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
30548 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
42194 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
gblx Increase Decrease In Accrued Liabilities Excluding Interest Payable
IncreaseDecreaseInAccruedLiabilitiesExcludingInterestPayable
7444 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
52990 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
41146 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-517825 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-907564 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
-0 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
30320 usd
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
235000 usd
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
235000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-30320 usd
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
220196 usd
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
75000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1595000 usd
gblx Payments For Brokerage Fees For Exercise Of Warrants
PaymentsForBrokerageFeesForExerciseOfWarrants
17753 usd
gblx Payments For Brokerage Fees For Exercise Of Warrants
PaymentsForBrokerageFeesForExerciseOfWarrants
207350 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
-0 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
25905 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
277443 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1361745 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5382 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
423861 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
109912 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
233893 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
104530 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
657754 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
gblx Patent Filing And Drafting Costs Capitalized In Intangible Assets
PatentFilingAndDraftingCostsCapitalizedInIntangibleAssets
7700 usd
gblx Patent Filing And Drafting Costs Capitalized In Intangible Assets
PatentFilingAndDraftingCostsCapitalizedInIntangibleAssets
27069 usd
gblx Compensation Warrants Issued To Brokers In Private Placement
CompensationWarrantsIssuedToBrokersInPrivatePlacement
0 usd
gblx Compensation Warrants Issued To Brokers In Private Placement
CompensationWarrantsIssuedToBrokersInPrivatePlacement
145150 usd
CY2023Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
269218 usd
CY2022Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
0 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2165711 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1278900 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6500 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-313057 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1193368 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-4680504 usd
CY2023Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
-0 usd
CY2023Q3 gblx Exercise Of Warrants For Stock Value
ExerciseOfWarrantsForStockValue
220196 usd
CY2023Q3 gblx Adjustments To Additional Paid In Capital Brokerage Fees On Exercise Of Warrants
AdjustmentsToAdditionalPaidInCapitalBrokerageFeesOnExerciseOfWarrants
-17753 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
219168 usd
CY2023Q3 gblx Adjustments To Additional Paid In Capital Warrant Reinstatement And Repricing
AdjustmentsToAdditionalPaidInCapitalWarrantReinstatementAndRepricing
269218 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
269218 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-434233 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-4693126 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1782872 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1387650 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13000 usd
us-gaap Net Income Loss
NetIncomeLoss
-811146 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1193368 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-4407383 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
-0 usd
gblx Exercise Of Warrants For Stock Value
ExerciseOfWarrantsForStockValue
220196 usd
gblx Adjustments To Additional Paid In Capital Brokerage Fees On Exercise Of Warrants
AdjustmentsToAdditionalPaidInCapitalBrokerageFeesOnExerciseOfWarrants
-17753 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
219168 usd
gblx Adjustments To Additional Paid In Capital Warrant Reinstatement And Repricing
AdjustmentsToAdditionalPaidInCapitalWarrantReinstatementAndRepricing
269218 usd
us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
269218 usd
us-gaap Net Income Loss
NetIncomeLoss
-707354 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-4693126 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Use of Estimates</i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to allowances for doubtful accounts, inventory valuation and standard cost allocations, valuation of initial right-of-use assets and corresponding lease liabilities, valuation of beneficial conversion features in convertible debt, valuation of the assets and liabilities of discontinued operations, stock-based compensation expense, purchased intangible asset valuations, deferred income tax asset valuation allowances, uncertain tax positions, litigation, other loss contingencies, and impairment of long lived assets.  These estimates and assumptions are based on current facts, historical experience and various other factors that the Company believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of costs and expenses that are <em style="font: inherit;">not</em> readily apparent from other sources. The actual results the Company experiences <em style="font: inherit;"> may </em>differ materially and adversely from these estimates.</p>
CY2023 gblx Debt Instrument Reclassification Of Debt To Convertible Notes Payable
DebtInstrumentReclassificationOfDebtToConvertibleNotesPayable
461077 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
172235838
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
31583334
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.07
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
31583334
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.07
CY2023 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
221650 usd
CY2023Q3 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Patent Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedPatentCosts
42194 usd
CY2023Q1 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Patent Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedPatentCosts
2374621 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
624 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
40492 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
183656554
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-109412669 usd
CY2023Q3 gblx Working Capital Deficit
WorkingCapitalDeficit
-4618126 usd
CY2023Q1 gblx Working Capital Deficit
WorkingCapitalDeficit
-4450202 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-517825 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-907564 usd
CY2023Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
1512307 usd
CY2023Q3 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
10674 usd
CY2023Q3 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1501633 usd
gblx Class Of Warrant Or Right Exercises In Period
ClassOfWarrantOrRightExercisesInPeriod
22015134
gblx Class Of Warrant Or Right Exercises In Period Exercise Price
ClassOfWarrantOrRightExercisesInPeriodExercisePrice
0.01
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
220196 usd
gblx Brokerage Fees Exercise Of Warrants
BrokerageFeesExerciseOfWarrants
17753 usd
CY2023Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
122758677
gblx Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
23006492
gblx Class Of Warrant Or Right Issued During Period Exercise Price
ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice
0.01
gblx Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
22015134
gblx Class Of Warrant Or Right Exercised During Period Exercise Price
ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice
0.01
gblx Class Of Warrant Or Right Cancelled During Period
ClassOfWarrantOrRightCancelledDuringPeriod
8086334
CY2023Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
115663701
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
23000000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.01
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
23000000

Files In Submission

Name View Source Status
0001437749-23-032645-index-headers.html Edgar Link pending
0001437749-23-032645-index.html Edgar Link pending
0001437749-23-032645.txt Edgar Link pending
0001437749-23-032645-xbrl.zip Edgar Link pending
ex_598519.htm Edgar Link pending
ex_598520.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gblx-20230930.xsd Edgar Link pending
gblx20230930_10q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
gblx-20230930_cal.xml Edgar Link unprocessable
gblx-20230930_def.xml Edgar Link unprocessable
gblx-20230930_lab.xml Edgar Link unprocessable
gblx-20230930_pre.xml Edgar Link unprocessable
gblx20230930_10q_htm.xml Edgar Link completed
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending